CLX Investment Company, Inc. (OTCBB: CLXN) today announced that portfolio investment Zonda Incorporated, which specializes in diagnostic tests that serve the medical, bacterial food safety, cosmetic, beverage, pharmaceutical, veterinary, and environmental sanitation testing markets, has entered into a distribution agreement for its HandiLab-C test for chlamydia in Spain. The agreement adds another new market to Zonda’s product distribution in Europe, where the HandiLab-C test is the only over-the-counter test (self testing) for chlamydia that carries the CE mark, which signifies that the product complies with the relevant European Union health, safety and environmental protection requirements.
